Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.83B 711M 622M 571M 533M 1.01B 67.72B 1.03B 6.86B 2.67B 33.29B 2.67B 2.61B 115B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.66B 686M 600M 551M 514M 975M 65.36B 990M 6.62B 2.57B 32.13B 2.58B 2.52B 111B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+1.47%
1 week+14.80%
Current month+8.21%
1 month+4.80%
3 months-17.17%
6 months+4.53%
Current year+4.53%
1 week 7.08
Extreme 7.08
8.56
1 month 7.08
Extreme 7.08
8.56
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.85
Manager TitleAgeSince
Chief Executive Officer 42 2017-12-10
Director of Finance/CFO 34 2019-07-31
Chief Operating Officer 45 2022-08-24
Director TitleAgeSince
Chairman 42 2019-07-31
Chairman 48 2019-03-20
Director/Board Member 46 2019-03-20
Date Insider Type Main position Quantity % Market Cap.
21-09-13Sell

Executive/Senior Manager

10,000 0.0025%
21-09-09Sell

Executive/Senior Manager

77,000 0.0189%
21-06-08Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+14.80%-17.08%+24.44% 711M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+31.35%+24.29% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +2.03%+4.69%+26.19%+54.48% 369.31B
Weighted average by Cap. +2.24%+5.53%+41.77%+82.99%

Financials

2024 2025
Net sales 984M 145M 127M 116M 109M 206M 13.8B 209M 1.4B 543M 6.78B 544M 532M 23.37B 1.21B 178M 155M 143M 133M 252M 16.91B 256M 1.71B 666M 8.31B 667M 652M 28.64B
Net income 13.65M 2.01M 1.76M 1.62M 1.51M 2.86M 191M 2.9M 19.4M 7.54M 94.13M 7.55M 7.39M 324M 92.73M 13.66M 11.94M 10.98M 10.23M 19.41M 1.3B 19.7M 132M 51.22M 639M 51.28M 50.18M 2.2B
Net Debt 189M 27.86M 24.35M 22.38M 20.86M 39.57M 2.65B 40.17M 269M 104M 1.3B 105M 102M 4.49B -169M -24.87M -21.74M -19.98M -18.62M -35.32M -2.37B -35.86M -240M -93.25M -1.16B -93.35M -91.35M -4.01B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
26-07-03 CN¥8.300 +1.47% 21,781,818
26-07-02 CN¥8.180 -0.73% 30,346,238
26-07-01 CN¥8.240 +7.43% 38,713,870
26-06-30 CN¥7.670 -2.29% 23,485,763
26-06-29 CN¥7.850 +8.58% 31,887,683

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock